IDEAYA Biosciences IDYA
NASDAQ IDYA
$34.71 -1.41 (-3.90%)
At close: Oct 23, 2026 · 4:00 PM EDT

IDEAYA Biosciences (IDYA) Sale and Maturity of Investments (2018 - 2026)

Updated

Analysis

IDEAYA Biosciences (IDYA) Sale and Maturity of Investments (2018 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 IDEAYA Biosciences 3.35 Bn 418.76 Mn - 158.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 158.37 Mn
Mar 31, 2026 162.53 Mn
Dec 31, 2025 138.95 Mn
Sep 30, 2025 180.80 Mn
Jun 30, 2025 174.13 Mn
Mar 31, 2025 186.35 Mn
Dec 31, 2024 141.03 Mn
Sep 30, 2024 194.15 Mn
Jun 30, 2024 234.29 Mn
Mar 31, 2024 123.14 Mn
Dec 31, 2023 110.50 Mn
Sep 30, 2023 133.78 Mn
Jun 30, 2023 99.75 Mn
Mar 31, 2023 95.86 Mn
Dec 31, 2022 55.23 Mn
Sep 30, 2022 70.50 Mn
Jun 30, 2022 53.18 Mn
Mar 31, 2022 46.94 Mn
Dec 31, 2021 32.76 Mn
Sep 30, 2021 93.53 Mn
API Access

IDEAYA Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=IDYA&period=max&api_key=YOUR_API_KEY